Upsher-Smith Launches Osteoporosis Therapy Fortical In U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
Unigene's nasal calcitonin-salmon product is expected to be sold primarily through managed care as an "economical alternative" to competing agents.